Survey of pediatric dermatologist views on treatment for alopecia areata
JAAD Int
.
2023 Aug 10:13:71-73.
doi: 10.1016/j.jdin.2023.06.016.
eCollection 2023 Dec.
Authors
David Bitterman
1
,
Dov Bitterman
1
,
Jacquelyn Sink
2
,
Katya Harfmann
3
,
Marcia Hogeling
4
,
Christine T Lauren
5
,
Kimberly D Morel
5
,
Leslie Castelo-Soccio
6
,
Nanette B Silverberg
1
7
Affiliations
1
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
2
Department of Dermatology, Northwestern Medicine Regional Medical Group, Naperville, Illinois.
3
Department of Dermatology, Nationwide Children's Hospital, Columbus, Ohio.
4
Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
5
Department of Dermatology and Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
6
Dermatology Branch, National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Health, Bethesda, Maryland.
7
Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York.
PMID:
37711340
PMCID:
PMC10498288
DOI:
10.1016/j.jdin.2023.06.016
No abstract available
Keywords:
JAK inhibitors; alopecia areata; alopecia totalis; alopecia universalis; corticosteroids.